Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry
Research output: Contribution to journal › Journal article › Research › peer-review
To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.
| Original language | English |
|---|---|
| Journal | Excerpta Medica. Section 31: Arthritis and Rheumatism |
| Volume | 65 |
| Issue number | 5 |
| Pages (from-to) | 1213-23 |
| Number of pages | 11 |
| ISSN | 0014-4355 |
| DOIs | |
| Publication status | Published - May 2013 |
ID: 48462465